Petauri Acquires Emotive to Expand Medical Communications

The Nashville-based firm adds Emotive, a global medical communications agency, to its Petauri Advance collective.

Updated on Nov. 10, 2026 in Healthcare

Petauri Acquires Emotive to Expand Medical Communications

Petauri has acquired Emotive, a global medical communications agency founded in 2013, and Emotive will join Petauri Advance alongside its existing strategic medical agencies. The acquisition adds scientific, strategic, and creative expertise, including depth in neuroscience, immunology, oncology, and rare disease.

Why it matters

The deal broadens the range of scientific and therapeutic areas covered by Petauri Advance, which now spans multiple specialty agencies. For Tennessee's healthcare communications sector, centered in Nashville, it reinforces the state's growing role in medical marketing and communications.

Petauri, which was founded in 2023, now employs more than 600 professionals globally following the addition of Emotive. Oak Hill will invest more than $250 million of equity capital in the initiative from its OHCP VI fund, though the source does not specify how much of that funds this acquisition.

The players

Petauri

Petauri is a Nashville, Tennessee-based medical communications company founded in 2023 that operates the Petauri Advance collective of strategic medical agencies.

Emotive

Emotive is a global medical communications agency founded in 2013 with expertise in neuroscience, immunology, oncology, and rare disease.

Chris Edmonds

Chris Edmonds is the founder and CEO of Emotive, who will take on an Executive Advisor role within Petauri after the acquisition.

Oak Hill

Oak Hill is an investment firm that will invest more than $250 million of equity capital in Petauri's initiative through its OHCP VI fund.

The details

Emotive, founded in 2013 and led by Founder and CEO Chris Edmonds, brings experience in neuroscience, immunology, oncology, and rare disease. Edmonds will serve as Executive Advisor within Petauri, and Emotive joins existing Petauri Advance agencies DRIVE, PROPEL, MOMENTUM, BluPrint Oncology, Verascity Science, and Cogency.

Timeline

  1. 2013: Emotive is founded.

  2. 2023: Petauri is founded.

  3. November 10, 2026: Petauri announces the Emotive acquisition.

Market Landscape

The deal extends Petauri Advance's model of building a collective of specialized medical agencies, now adding Emotive's neuroscience, immunology, oncology, and rare disease capabilities to six existing agencies. It positions Petauri to compete for pharmaceutical and biotech communications work across a wider set of therapeutic areas.

For pharmaceutical and biotech clients, the acquisition may expand the range of communications services available through a single collective. Patients and the general public will not see a direct change from this corporate transaction.

The takeaway

Consolidation among medical communications agencies is bringing specialty expertise under single holding structures, which can make cross-therapeutic campaigns easier to coordinate. Readers tracking Tennessee's healthcare industry will want to watch how Nashville-based firms continue to grow.

Further reading

For more on the business of healthcare, see Healthcare coverage from Tennessee.

Source note: This article includes information reported by PMLive.